Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,725.63
(
0.49%
)
News Focus
News Focus
Post# of 257661
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123040
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 221380

Tuesday, 06/18/2019 11:09:22 AM

Tuesday, June 18, 2019 11:09:22 AM

Post# of 257661
FDA approves Keytruda monotherapy in third-line SCLC:

https://finance.yahoo.com/news/fda-approves-merck-keytruda-pembrolizumab-104500587.html

This is an accelerated approval based on data from the KEYNOTE-158 and KEYNOTE-028 studies.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today